Marked influence of the route of infection on prion strain apparent phenotype in a scrapie transgenic mouse model.
Prion strains yield specific neuropathological features including spongiform degeneration and deposition patterns of pathological prion protein. Their invariant regional distribution, following variations in the infection route, has led to the proposal that prions replicate preferentially in defined neuro-anatomical areas. The molecular mechanisms underlying this apparent strain-specific neuronal tropism are currently unknown. However, a possible explanation may be that prion replication is relatively innocuous, resulting in long-term propagation, thus masking initial regional distribution variations linked to different infection routes. This "low neurotoxicity" may be imputable either to the rodent model used or the prion strain(s) inoculated. To investigate this possibility, we studied prion pathogenesis in a prototypal short-incubation disease model consisting of 127S scrapie strain propagated in tg338 transgenic mice expressing the VRQ allele of ovine PrP. This prion strain derives from a natural sheep scrapie isolate that was serially transmitted to tg338 mice without any obvious transmission barrier and biologically cloned by limiting dilution. We compared the pathology induced by the peripheral or intracerebral inoculation of 127S strain. Surprisingly, we found that the disease greatly differed in clinical signs, abnormal prion protein levels, and neuropathology among the routes of infection. Secondary transmission performed with brain material from mice inoculated either intracranially or intraperitoneally produced similar neuropathological features. These results therefore indicate that the route of infection can strongly influence the apparent phenotype of a scrapie strain.
Langevin
Christelle
C
INRA (Institut National de la Recherche Agronomique), UR892, Virologie Immunologie Moléculaires, F-78350 Jouy-en-Josas, France.
Andréoletti
Olivier
O
Le Dur
Annick
A
Laude
Hubert
H
Béringue
Vincent
V
D000818:Animals; D004195:Disease Models, Animal; D018562:Disease Transmission, Infectious; D007267:Injections / Q000379:methods; D007274:Injections, Intraperitoneal / Q000379:methods; D051379:Mice; D008822:Mice, Transgenic; D009474:Neurons / Q000378:metabolism / Q000473:pathology; D010641:Phenotype; D018620:PrPSc Proteins / Q000235:genetics / Q000378:metabolism / Q000472:pathogenicity*; D020033:Protein Isoforms / Q000235:genetics / Q000378:metabolism; D012608:Scrapie / Q000209:etiology / Q000235:genetics* / Q000473:pathology*; D034561:Sheep, Domestic
D018620:PrPSc Proteins; D020033:Protein Isoforms